Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Roche announced today that the European Medicines Agencys Committee for Medicinal Products for Human Use has adopted a positive opinion for PiaSky for the treatment of paroxysmal nocturnal haemoglobinuria
Regeneron Pharmaceuticals Inc today announced that the European Medicines Agencys Committee for Medicinal Products for Human Use has adopted a positive opinion recommending conditional marketing
Merck known as MSD outside of the United States and Canada announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended the approval of WINREVAIR
GenVivo Inc a private clinicalstage biopharmaceutical company with breakthrough offtheshelf platforms for cancer gene medicine immunotherapies announced
AbbVie announced today the acquisition of Celsius Therapeutics Inc a privately held biotechnology company pioneering new therapies for patients with inflammatory disease Celsius lead investigational asset is CEL a potential firstinclass antiTREM anti...
Harbour BioMed a global biopharmaceutical company committed to the discovery development and commercialization of novel antibody therapeutics focusing
Vir Biotechnology Inc today announced that the US Food and Drug Administration has cleared its investigational new drug application and granted Fast Track designation for the combination
Synaptogenix Inc an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders today announced that the Food Drug Administration
Tempus AI Inc a leader in artificial intelligence and precision medicine today announced a new collaboration with United Therapeutics a leading biotechnology
Halozyme Therapeutics Inc today announced that Roche received European Commission marketing authorization of OCREVUS SC coformulated
